Healthcare
from24/7 Wall St.
1 week agoDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
IHE has outperformed healthcare benchmarks over the past year despite MFN drug pricing threats, but concentration risk means future policy impacts may still affect margins.